In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells.

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Tissue Engineering

Background:

• Clinically relevant regenerative therapies require expandable cell populations for 3D tissue formation in vivo.
• Human embryonic stem cells (hESCs) offer a potential source for such cells.

Purpose of the Study:

• To develop an efficient method for deriving and characterizing mesenchymal stem cells (MSCs) from hESCs (hESCd-MSCs).
• To evaluate the in vitro differentiation potential and in vivo survival and efficacy of hESCd-MSCs in cartilage regeneration.

Main Methods:

• Derivation and characterization of hESCd-MSCs.
• In vitro assessment of multilineage differentiation (adipogenesis, chondrogenesis, osteogenesis).
• In vivo evaluation of hESCd-MSC survival and chondrogenic commitment in a rat osteochondral defect model using morphogenetic factors and hydrogels.

Main Results:

• hESCd-MSCs demonstrated multilineage differentiation potential in vitro.
• Chondrogenically-committed hESCd-MSCs survived and integrated into the defect site in vivo.
• Normal cartilage architecture was restored in rat osteochondral defects treated with hESCd-MSCs.

Conclusions:

• hESCd-MSCs provide a readily expandable cell source with multilineage potential.
• These cells are effective in regenerating cartilage tissue in vivo.
• hESCd-MSCs hold significant promise for musculoskeletal tissue regeneration applications.